BioSpace News Archive

Drug Development

Lycera Announces Initiation of Phase Ib Study of Novel Immuno-Oncology Candidate LYC-55716 in Combination with Pembrolizumab

Lycera’s Phase 1b study is expected to enroll a total of approximately 18 patients with metastatic NSCLC.

January 4, 2018
·
4 min read
Business

Beacon Discovery Announces Multi-Year GPCR-Focused Drug Discovery Collaboration With Janssen

Beacon Discovery today announced it has entered into a collaboration agreement with Janssen.

January 4, 2018
·
2 min read
BioMidwest

Colorado’s SomaLogic Closes $200M Financing Round

The successful round will accelerate SomaLogic’s goal of becoming the world’s leading provider of precision digital health insights.

January 4, 2018
·
3 min read
Pharm Country

Amneal Biosciences Introduces Busulfan Injection, Generic for Busulfex

Amneal Biosciences has launched busulfan injection, the company’s AP-rated therapeutic equivalent for Busulfex 60 mg/10 mL.

January 4, 2018
·
1 min read
Business

Triumvira Names a New CEO

Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries.

January 4, 2018
·
3 min read
Drug Development

Exelixis Announces Amendment to Clinical Research Protocol for Phase Ib Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Exelixis today announced an amendment to the protocol for the phase 1b trial of cabozantinib in combination with atezolizumab (TECENTRIQ) in patients with locally advanced or metastatic solid tumors.

January 4, 2018
·
17 min read
Business

Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation

Pierre Fabre Pharmaceuticals (Pierre Fabre) and Boston Pharmaceuticals Inc. (Boston Pharmaceuticals) today announced they have entered into a worldwide licensing agreement for Pierre Fabre’s selective potassium channel blocker, F17727.

January 4, 2018
·
4 min read
Business

Recros Medica Closes $9M Financing, Strengthens Board

Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal, MD, PhD and Mark Kerslake.

January 4, 2018
·
3 min read
Biotech Bay

Fluxion Biosciences Announces Launch of ERASE-Seq NGS Liquid Biopsy Analysis Service

Fluxion Biosciences announced today that its ERASE-Seq bioinformatics solution can now be utilized for variant calling from a wide range of targeted cancer panels.

January 4, 2018
·
2 min read
Biotech Beach

Hycor Biomedical Applies CE Mark to IVD Allergy Instrument: NOVEOS

Hycor Biomedical announced today that it has applied the CE mark to its allergy testing system, NOVEOS, along with an initial menu of Total IgE and over one hundred Specific IgE allergen reagents.

January 4, 2018
·
2 min read